Save time and get answers to complex questions with AI chat
Drugpatentwatch crizotinib?Antiox mebendazole price?Pramlintide acetate price?When will tenofovir alafenide come off patent in canada?Zemdri nce gain exclusivity 2028 patent 2031?
See the DrugPatentWatch profile for gemtesa
The generic name for Gemtesa is vibegron [1].
Vibegron is a medication prescribed to treat adults with overactive bladder (OAB) [1]. OAB is a condition characterized by a sudden, frequent urge to urinate, which can lead to incontinence [2].
Vibegron is a beta-3 adrenergic agonist. It works by relaxing the detrusor muscle, the bladder muscle that contracts to release urine. By relaxing this muscle, vibegron increases the bladder's capacity to store urine and reduces the urgency and frequency of urination [1][2].
Information regarding the specific patent expiry dates for vibegron is available through resources like DrugPatentWatch.com [3]. Patent protection is crucial for pharmaceutical companies, influencing the timeline for generic competition.
Gemtesa is manufactured by Urovant Sciences [4].
Other Questions About Gemtesa :